Mood disorders Flashcards

1
Q

Bipolar depression

A

Worse or wired when taking ADT (agitated/restless) - agitation if SE should improve over time
Hypomania, hyperthymic temperament or mood swings in history
Irritable, hostile or mixed features
Psychomotor retardation
Loaded fhx: BPAD, affectivity, mood swings
Abrupt onset and or termination of depressive episodes in <3mths
Seasonal or postpartum depression
Hyperphagia and hypersomnia
Early age of onset - early 20s
Delusions Hallucinations and Psychotic features

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Bipolar depression mx

A

lamotrigine - 25mg increased 25mg every 2 weeks
quetiapine 300-600
olanzapine + fluoxetine

2nd line add mood stabiliser

then add antidepressant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Mixed features in depression

A

Inner tension/agitation
Racing or crowded thoughts
Irritability
No psychomotor retardation
Talkativeness
Dramatic description of suffering or frequent spells of weeping
Mood lability and marked emotional reactivity
Early insomnia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Ix AND Treatment of depression with mixed features

A

Rule out organic e.g. hyperthyroid, TBI
Rule out substance use or meds- L dopa, steroids
Assess for hypomania, fhx of BPAD
1st line: lurasidone, quetiapine, aripiprazole
2nd line: lamotrigine, valproate, lithium, olanzapine

ADT mono generally not recommended

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Sx of melancholic depression

A

anhedonia
retardation
neurocognitive - concentration
guilt worthlessness
suicidality
neurovegetative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Chronic pain and depression pathophys

A

pain - cognitive distortions e.g. dependence on meds - increased feelings of helplessness - withdrawal from physical and social activities - intensification of depression - influence on perception and reactions to pain - more pain

behavioural activation, cognitive restructuring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Rapid cycling presentation

A
  • four or more episodes of mood disorder fulfilling criteria for mania or depression
    over a 12-month period
  • It is also used to describe mood disorder that rapidly changes from one mood state to
    other without periods of remission
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Rapid cycling mx

A

Exclude non compliance
Stop antidepressant
Thyroid disorder (subclinical hypothyroidism)
Substance use
Lithium + valproate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Atypical depression dx and mx

A

Mood reactivity
hypersomnia hyperphagia
leaden paralysis
interpersonal sensitivity

phenelzine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Chronic adjustment disorder

A

Significant adjustment issues such as loss of role, family, untreated grief
Post migration stresses
Loss of identity
Unemployment
Family conflict
Loss of cultural identity
Stereotyping
Racism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Profession and ethical issues in involuntary patient

A
  1. Autonomy - may or may not be able to consent to ECT due to lack of capacity. This may be related to severity of illness, therefore ax of decision making capacity and explore pt wishes
  2. Privacy and confidentiality. Respect confidentiality of pt and obtain consent to speak to family members
  3. Benefience - The patient has symptoms of ___ that is associated with high risk of ___.
    ___ is an evidence based treatment for ___ and has a high response rate
    Therefore the treatment may be in the best interest of the pt
  4. Non malefience - withholding ___ may increase the risk of suicide
  5. Advanced directives - look at advanced directives and previous wishes. Second opinion. MHA legislation if fulfils criteria for significant risk and pt lacks capacity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Factors contributing to depression failing to improve

A

-Treatment resistant depressive nature associated with nihilistic delusions and agitation, which indicates psychotic depression
-Which requires broad spectrum ADT e.g. SNRI/TCA at high doses (dopaminergic and noradrenergic antidepressants)
Venla 225 for 3 weeks is subtherapeutic dose and duration
-Needs antipsychotic

-Severe vasculopathy, psychotic depression may be associated with vascular features

-Organic factors: hyponatremia, thyroid, addison’s disease, brain tumour, neurocognitive impairment contributing to tx resistance

-Non compliance

-Psychological factors - however psychotic has more biological weighting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Factors contributing family opposition to ECT

A
  1. Stigma against ECT due to media perception
  2. Negative attitude due to negative past experiences
  3. Lack of knowledge about modern techniques of ECT. Psychoeducation not provided about the benefits and risks in a detailed manner
  4. Concerns about side effects of ECT. Explanation not provided about different electrode placements and techniques to minimise cognitive deficits
  5. Family may be respecting pt wishes
  6. Poor engagement with treating team or psychiatrist, transference and countertransference issues
  7. Cultural factors or beliefs in alternate models of care
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Mx of ECT induced hypomania

A
  1. Stop ECT, wait and watch
  2. Space out the ECT and monitor for worsening hypomania
  3. Reduce dose of ADT with aim of ceasing, gradual cessation due to anticholinergic rebound
  4. Optimise mood stabiliser for tx of mania
  5. Lithium augmentation for tx resistant depression and mania
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Differences in mood stabiliser properties

A
  • Lithium has more antimanic properties
  • Lamotrigine has greater effect for depression
  • Valproate is more effective for mixed episodes

lamotrigine + valproate - need to reduce lamotrigine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Main considerations in initiating Li

A
  • Narrow therapeutic index
  • Renally excreted
  • Not hepatically metabolised
  • Start at dose of 250 mg BD and measure
    levels after seven days and after one week after each dose change
  • Levels measured 12 hrs post dose
  • Once stable check three monthly
  • Check renal and thyroid functions six monthly
  • Levels aimed are between 0.6 and 1.2 mmol/l
  • Sudden stopping of lithium increases the chance of rebound
  • It is recommended that lithium treatment should not be started unless there is a clear
    intention that it is to be continued for at least three years
17
Q

Main adverse effects of lithium and management

A
  • Side effects are dose related and increase in frequency when levels are above 1
    mmol/l
  • Mild side effects - fine hand tremor, thirst and polyuria, nausea (transient)
  • Acne and psoriasis can be worsened

Toxicity
* Levels >1.5 mmol/l
* GI effects – Anorexia, vomiting and diarrhoea
* CNS effects – muscle weakness, drowsiness, ataxia, coarse tremor, and muscle
twitching

  • Levels >2.0 mmol/l (emergency)
  • Management in ICU with cardiac, renal monitoring
  • Delirium
  • Myoclonus
  • Coma
  • Osmotic dieresis or forced alkaline dieresis
  • Above 3.0 mmol/l – peritoneal or hemodialysis
18
Q

Endocrine and renal complications of Li

A

Endocrine side effects of lithium
* Hypothyroidism (more common in women)
* Hyperthyroidism
* Hypoparathyroidism
* Hyperparathyroidism

Renal complications of lithium (in order of frequency of occurrence)
* Small reduction in glomerular filtration rate
* Interstitial nephritis
* Reduction in urinary concentrating capacity (nephrogenic diabetes insipidus),
reversible in short term but irreversible after long-term treatment

19
Q

Drug interactions of Li

A
  • Diuretics: thiazides most commonly associated with increased serum lithium levels
    as the kidney cannot distinguish between sodium and lithium at the proximal tubule
  • NSAIDs increase lithium levels by about 40%
  • ACEI and Angiotensin 2 antagonists increase the lithium level by decreasing
    excretion